Vazzano Joseph Walter 4

What Happened Joseph Walter Vazzano, Chief Financial Officer of Abeona Therapeutics, reported a sale of 785 shares on March 16, 2026. The shares were disposed at $4.76 per share for a total proceeds of approximately $3,737. The filing indicates this sale was to satisfy tax obligations tied to the vesting of restricted stock awards, so it was a withholding-type sale rather than an independent investment decision.

Key Details

• Transaction date: 2026-03-16
• Transaction type: Sale (code S) — reported as "open market or private sale"
• Shares sold: 785 at $4.76 per share; proceeds ≈ $3,737
• Footnote: Sale was to cover tax obligations from vesting of restricted stock awards (Footnote F1)
• Shares owned after transaction: Not specified in the provided excerpt
• Filing timeliness: Reported on the same date as the transaction; no late filing flagged in the provided information

Context Sales to cover tax withholding on vested awards are common and typically routine; they do not necessarily indicate a view on company prospects. The transaction size here is small in absolute dollar terms. Retail investors should weigh this informational point alongside broader insider activity and company fundamentals.